Special Issue on Esophageal Cancer

Esophageal Cancer is malignancy of the esophagus. There are various subtypes, primarily squamous cell cancer (approx 90–95% of all esophageal cancer worldwide) and adenocarcinoma (approx. 50–80% of all esophageal cancer in the United States). Squamous cell cancer arises from the cells that line the upper part of the esophagus. Adenocarcinoma arises from glandular cells that are present at the junction of the esophagus and stomach. Esophageal tumors usually lead to dysphagia (difficulty swallowing), pain and other symptoms, and are diagnosed with biopsy. Small and localized tumors are treated surgically with curative intent. Larger tumors tend not to be operable and hence are treated with palliative care; their growth can still be delayed with chemotherapy, radiotherapy or a combination of the two. In some cases chemo- and radiotherapy can render these larger tumors operable. As one of the most important research fields of human life, esophageal cancer is of great attractions to researchers.

In this special issue, we intend to invite front-line researchers and authors to submit original researches and review articles on exploring esophageal cancer. Potential topics include, but are not limited to:

• Adenocarcinoma
• Squamous cell carcinomas
• Gastroesophageal reflux disease
• Barrett's esophagus
• Odynophagia
• Regurgitation of food
• Esophagectomy

Authors should read over the journal’s Authors’ Guidelines carefully before submission, Prospective authors should submit an electronic copy of their complete manuscript through the journal at Paper Submission System.

Please kindly notice that the “Special Issue” under your manuscript title is supposed to be specified and the research field “Special Issue - Esophageal Cancer” should be chosen during your submission.

According to the following timetable:

Guest Editor:

Prof. Sibu P. Saha

University of Kentucky, USA

For further questions or inquiries

Please contact Editorial Assistant at

jct@scirp.org